Invion Reports 79% Disease Control in Phase 1 Skin Cancer Trial
Invion closed Phase 1 recruitment in non-melanoma skin cancer, reporting 79% disease control across 14 patients — an early signal now awaiting full data readout.
Topic
Non Melanoma Skin Cancer
Topic
Non Melanoma Skin Cancer
Basosquamous Carcinoma: A Skin Cancer That Refuses to Sit in One Box
Basosquamous carcinoma blends basal cell and squamous cell features, and its disputed classification continues to shape how derma…
UC San Diego Health Begins Offering Band-Aid-Style Patch for Skin Cancer
UC San Diego Health is offering a band-aid-style adhesive patch to treat skin cancer, moving topical tumor therapy into a wearabl…
Gut Bacteria Predict Skin Cancer Recurrence, Study Finds
NYU Langone links gut bacteria to skin cancer recurrence, but only when patients share a microbial fingerprint — reframing earlie…
FDA Approves Light-Based Therapy for a Common Skin Cancer
The FDA has approved a light-based treatment for a common skin cancer, adding a nonsurgical phototherapy option for non-melanoma…
UC San Diego Health First Hospital to Deploy CivaDerm Radioactive Bandage for Skin Cancer
UC San Diego Health has become the first hospital to use CivaDerm, a radioactive bandage for treating skin cancer — a first-in-ho…
CivaTech's CivaDerm Reaches First Commercial Use in Skin Cancer
CivaTech Oncology of Morrisville announces first commercial use of CivaDerm for non-melanoma skin cancer, moving the device into…
FDA Approval of Ameluz Expands Skin Cancer Treatment Options
The FDA has approved Ameluz, a decision specialists hail as a meaningful addition to the skin cancer treatment armamentarium, Med…
Rhenium-188 Epidermal Radionuclide Therapy in Non-Melanoma Skin Cancer
A Frontiers narrative review surveys epidermal radionuclide therapy with rhenium-188, a topical beta-emitter approach to basal an…
Preclinical Data Suggest New Cream May Slow Common Skin Cancers
Penn Medicine reports preclinical evidence that a new topical cream may prevent or slow growth of common skin cancers; no human d…